ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

Childhood Cancer Survivors May Have Early Heart Problems

July 25, 2003

$3.3 Million For Retinoid Contract Awarded

October 14, 1977

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

June 1, 2001

NCI plans to cut staff access to The Cancer Letter; insiders allege attempt at “thought control.”

November 18, 2005

Construction Money In Budget Earmarked For Frederick

February 9, 1990

Prime Contract Subcontract Opportunities

January 24, 1975